CAPR vs INTU · $1.62B cap vs P/E 64, rev $18.83B
Capricor Therapeutics Inc (CAPR) versus Intuit Inc (INTU) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Intuit Inc (INTU) is a software - application company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
CAPR currently screens at market cap $1.62B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Not investment advice. Open the CAPR and INTU stock pages for the full models.
Not investment advice.